Clinical Trial Alert

Advertisement
Clinical Trial Alert with image of researcher's gloved hand holding a test tube
Blog Post

Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults with Generalized Myasthenia Gravis (gMG)

By Sujatha Gurunathan | March 9, 2023
Blog Post

Clinical Trial Alert: Phase 2 Study of EDG-5506 in Adults or Adolescents with BMD

By Sujatha Gurunathan | February 1, 2023
Clinical Trial Alert with image of researcher's gloved hand holding a test tube
Blog Post

Clinical Trial Alert: Medical Device Feasibility Study for People with Paralysis

By Sujatha Gurunathan | December 14, 2022
Clinical Trial Alert with image of medical researcher looking at computer screen
Blog Post

Clinical Trial Alert: Phase 2 Study of a New Tool for Muscle Assessment in People with Neuromuscular Disease

By Sujatha Gurunathan | December 14, 2022
Blog Post

Clinical Trial Alert: Phase 2 Study of Vamorolone in Adults with BMD

By Sujatha Gurunathan | November 7, 2022
Green background reads Clinical Trial Alert with a semi circle image of a scientist's hand and beakers
Blog Post

Clinical Trial Alert: Phase 3 Study of Inebilizumab in Adults with Myasthenia Gravis

By Sujatha Gurunathan | October 24, 2022
Blog Post

Clinical Trial Alert: Phase 3 Study of IgPro20 in Adults with Dermatomyositis

By Sujatha Gurunathan | August 17, 2022
clinical-trial-alert-image
Blog Post

Clinical Trial Alert: Phase 2 Study of Oral Ifetroban in Individuals with DMD

By Sujatha Gurunathan | August 10, 2022
Blog Post

Clinical Trial Alert: Phase 3 Study of investigational drug in Adults Living with ALS

By Sujatha Gurunathan | May 17, 2022
MG clinical trial
Blog Post

Clinical Trial Alert: Phase 2 Study of ALXN2050 in Adults Living with gMG

By MDA Staff | April 6, 2022